binding was normal throughout the entire rostrocaudal extent of the basal ganglia (including striatum and nucleus accumbens), cerebral cortex, and diencephalon, as well as in midbrain and brainstem monoamine cell body regions, both on the last day of cocaine access and after 3 weeks of drug withdrawal.
Although much evidence suggests that the brain dopamine transporter (DAT) is susceptible to dopaminergic regulation, only limited information is available for the vesicular monoamine transporter (VMAT2). In the present investigation, we used a chronic, unlimited-access, cocaine self-administration paradigm to determine whether brain levels of VMAT2, as estimated using rH]dihydrotetrabenazine (DTBZ) binding, are altered by chronic exposure to a dopamine uptake blocker. Previously, we showed that striatal and nucleus accumbens DAT levels, as estimated by [3H]WIN 35, 428 and [3H] GBR 12,935 binding, are altered markedly using this animal model (Wilson et al., 1994) .
However, in sequential sections from the same animals, rH]DTBZ binding was normal throughout the entire rostrocaudal extent of the basal ganglia (including striatum and nucleus accumbens), cerebral cortex, and diencephalon, as well as in midbrain and brainstem monoamine cell body regions, both on the last day of cocaine access and after 3 weeks of drug withdrawal.
These data provide additional evidence that VMAT2, unlike DAT, is resistant to dopaminergic regulation. Key words: cocaine; vesicular monoamine transporter; dihydrotetrabenazine; quantitative autoradiography; self-administration; unlimited access
In dopaminergic nerve terminals, dopamine is packaged into synaptic vesicles by the vesicular monoamine transporter (VMAT2). Synaptic vesicles exist in two functional pools: a releasable pool and a reserve pool (Greengard et al., 1993; Kelly, 1993) . Vesicles in the releasable pool are held close to the plasma membrane, and upon depolarization of the nerve terminal, release dopamine into the synaptic cleft where it can interact with receptors to initiate a cellular response. The vesicles in the reserve pool, in contrast, are linked to the cytoskeleton and are recruited to the release pool to maintain the physiological requirements of the cell. Neurotransmission is terminated by the removal of dopamine from its site of action, mediated primarily through reuptake into the presynaptic nerve terminal via the plasma membrane dopamine transporter (DAT). Once inside the nerve terminal, dopamine can be stored in a cytoplasmic pool or packaged into synaptic vesicles via VMAT2. Both DAT and VMAT2 have been proposed as indices of presynaptic nerve terminal integrity. Radiotracers have been developed for imaging these sites using in vitro (ligand binding and autoradiography) and in vivo (positron emission tomography and single photon emission computerized tomography techniques) (Schoemaker et al., 198.5; Scherman et al., 1988; Frost et al., 1993; Innes, 1994; Vander Borght et al., 1995) .
Experimental evidence suggests that striatal and nucleus accumbens DAT levels, as estimated by radioligand binding techniques, can be altered markedly, independent of changes in dopamine nerve terminal density, to maintain normal synaptic dopamine levels. Although the data are not entirely consistent (see Wilson et al., 1994) striatal DAT concentrations can be elevated after administration of drugs that enhance synaptic dopamine levels (Weiner et al., 1989; Vander Borght et al., 1995) and reduced after administration of dopamine-depleting drugs (Kilbourn et al., 1992) . Similarly, during chronic administration of the dopamine uptake blocker cocaine, which results in elevated synaptic dopamine levels (Pettit and Justice, 1991) DAT levels are increased (Alburges et al., 1993; Wilson et al., 1994) whereas during cocaine withdrawal, a state associated with subnormal synaptic dopamine concentrations (Parsons et al., 1991) , DAT levels are reduced (Hitri et al., 1989; Sharpe et al., 1991; Farfel et al., 1992; Wilson et al., 1994) . Although these data suggest that DAT is subject to dopaminergic regulation, the mechanism through which the regulatory changes are mediated remains to be determined. However, some evidence suggests the involvement of the dopamine D2 receptor in modulating DAT function (Cass and Gerhardt, 1994) .
Only limited information is available with respect to the susceptibility of VMAT2 to dopaminergic regulation. Although two recent investigations have suggested that VMAT2 is not regulated readily by drugs that alter synaptic dopamine concentration or dopamine receptor function (Naudon et al., 1994; Vander Borght et al., 1995) these studies have been limited to short-term drug treatments (2 d and 2 weeks, respectively). Therefore, in the present investigation, we assessed whether binding of [3H]dihydrotetrabenazine (DTBZ) to VMAT2 is altered after chronic (7 weeks) perturbation of the dopamine system with cocaine. An unlimited-access self-administration paradigm was used, in which rats received high doses of cocaine (-90 mg/kg per day). This paradigm has previously demonstrated marked up-and downregulation of the DAT during cocaine access and withdrawal, respectively (Wilson et al., 1994) .
MATERIALS AND METHODS
An unlimited cocaine self-administration paradigm was used to investigate the influence of prolonged, high-dose cocaine exposure on VMAT2. The results presented here were obtained from sequential brain sections from the same animals used in a previous iniestigation, in which I'HlWIN 35.428 and I"HlGBR 12.935 bindine to the DAT was measured.
and' in which the self-administration parad;gm has been described in detail (Wilson et al., 1994) . Briefly, male Wistar rats (350 to 400 gm) were implanted with chronic indwelling jugular vein catheters and allowed to recover from surgery for 24-48 hr. The rats lived in their operant chambers for the duration of the experiment. The chambers contained two response levers, a food receptacle, and a standard water bottle. A stimulus light was mounted above each lever and was illuminated for the duration of an infusion (3-4 set) after a response was made. Infusion pumps were located outside sound-attenuating wooden enclosures. One to 2 d after surgery, the drug-naive rats, with no previous experience in the operant chamber, were given unlimited access to cocaine selfadministration. Daily sessions began at 10:00 A.M. and lasted 24 hr/d for at least 3 weeks (mean self-administration period = 7 weeks 2 5 d). Cocaine (0.1 mg per infusion) was delivered after a response on the left lever, and the dose was controlled by the duration of infusion (1 set per 100 gm body weight). Food intake was limited to 20 gm/d during the self-administration period. Because the experimental chamber acts as the home environment for the self-administering animals, control animals (n = 15, age-and food-matched) remained in their home cages throughout.
One group of rats (on-cocaine group, n = 10) was killed on the last day of cocaine access with no withdrawal from cocaine. The maximal interval between the last cocaine infusion and death was 4 hr. A second group (cocaine-withdrawn group, n = 8) was killed after a 3 week withdrawal period. Rats were killed by decapitation and the brain removed rapidly and divided longitudinally into two halves. One half was frozen immediately over dry ice and stored at -80°C until cryostat sectioning. Serial coronal sections (20 pm) were cut at -2O"C, thaw mounted onto gelatincoated slides, and stored at -80°C until assayed. The second half was dissected over a cold plate into discrete brain areas that were stored at -80°C and retained for measurement of monoamines and metabolites (Wilson et al., 1994) .
Binding of ['HIDTBZ to the vesicular monoamine transporter was assessed using minor modifications of the procedure of Rostkne and colleagues (1992). Brain sections were preincubated for 20 min at 25°C in 50 mM sodium phosphate buffer, pH 7.7, to remove any residual cocaine that might be present, then incubated for 40 min in the same buffer containing 5 nM ["HIDTBZ (155 Ciimmol, Amersham, Oakville, Ontario, Canada) in the presence (nonspecific binding) or absence (total binding) of 2 FM tetrabenazine. The concentration of [3H]DTBZ was equal to the equilibrium dissociation constant (&) for [3H]DTBZ binding in rat striatum (Darchen et al., 1989) and was chosen to permit detection of changes in both affinity (&) and density (B,,,) of VGAT2. Sections were washed twice in buffer at 0-4°C for 3 min and rinsed in distilled water before drying. Dried sections were apposed to tritium-sensitive film (Eastman Kodak Hyperfilm, Rochester, NY) at 0-4°C for 2 weeks in the presence of tritium-calibrated "'C-labeled standards. Films were developed using Kodak D19 developer, and densitrometric analysis of autoradiograms was performed using a camera-based computerized imaging device (MCID, Imaging Research, St. Catharines, Ontario, Canada).
As described in detail previously (Wilson et al., 1994) , brain areas were subdivided in anterior-posterior, dorsoventral, and mediolateral planes where appropriate.
RESULTS

Cocaine self-administration
The mean daily cocaine intake in rats given unlimited access to self-administration of cocaine was 36.8 ? 4.2 mg/d (-90 mg/kg per day). There were no statistically significant differences (using an unpaired Student's t test) in mean daily cocaine intake between the on-cocaine (42 ? 4 mg) and cocaine-withdrawn (30 ? 8 mg) groups. In addition, there were no significant differences between total cocaine intake (on-cocaine, 1700 2 290 mg; cocainewithdrawn, 1690 2 350 mg; p > O.OS), maximum daily intake (on-cocaine, 132 ? 18 mg; cocaine-withdrawn, 111 ? 26 mg;p > 0.0.5), or duration of access (on cocaine, 41 ? 6 d; cocainewithdrawn, 60 ? 7 d; p > 0.05) between the on-cocaine and cocaine-withdrawn groups. The daily patterns of cocaine intake have been described previously (Wilson et al., 1994 (Scherman, 1986; Scherman et al., 1986; Scherman et al., 1988; Darchen et al., 1989; Rostene et al., 1992) . The highest density of ["HIDTBZ binding was in the dopamine-rich areas of striatum, nucleus accumbens, and olfactory tubercle. Lesions of the nigrostriatal pathway with 6-hydroxydopamine result in a marked depletion of ['HIDTBZ binding sites in rat striatum (Darchen et al., 1989; Masuo et al., 1990) , together with reduced tyrosine hydroxylase activity (Masuo et al., 1990) , suggesting that a substantial proportion (-95%) of striatal ["HIDTBZ binding is to dopaminergic nerve terminals (Masuo et al., 1990) . Based on the relative concentrations of dopamine and serotonin in striatum, it generally is assumed that only -5% of monoaminergic neurons in the striatum are serotonergic (Scherman et al., 1986 Data are subregional distribution (mean 2 SEM; pmol/pg tissue) of ['H]DTBZ binding in brain of control rats (n = 15) and of rats killed on the last day of (n = 10) or 3 weeks after withdrawal from (n = 8) chronic, unlimited access to self-administration of cocaine. ligands in the caudal body of the striatum, with the highest binding density detected in the ventral subdivision. Previously we have reported differential localization of ['HIGBR 12, 935 and ['HIWIN 35, 428 binding sites (highest density in dorsomedial and ventrolateral subdivisions, respectively) in the rostra1 body of the striatum (Wilson et al., 1994) , suggesting that these ligands might bind to different affinity states or variants of the DAT. The density gradients observed for ["HIDTBZ binding in the striatum could reflect a composite of ['HIGBR 12, 935 and ["HIWIN 35, 428 binding sites, suggesting that ['HIDTBZ binds to all dopaminergic nerve terminals, irrespective of the expressed form of DAT.
Although ["HIDTBZ binding is predominantly to dopaminergic nerve terminals in the basal ganglia, significant binding, as expected, was detected in other brain areas that contain noradrenergic and serotonergic innervation (hypothalamus, septum), as well as in the corresponding ceil body areas (locus coeruleus and raphe nuclei).
Cocaine and the vesicular monoamine transporter
The present results demonstrate that ["H]DTBZ binding in rat brain was unaltered after chronic, unlimited access to selfadministration of high doses (-90 mg/kg per day) of cocaine, both on the last day of cocaine access and after a 3 week withdrawal period. These findings are consistent with the recent demonstration from two independent studies (Naudon et al., 1994; Vander Borght et al., 1995) that pharmacological agents that modify synaptic dopamine concentration (mazindol, deprenyl, L-dopa) or dopamine receptor function (haloperidol, bromocriptine, apomorphine)
do not alter brain VMAT2 concentration. This is in contrast to DAT, which undergoes marked up-and downregulation after administration of drugs that enhance (Weiner et al., 1989; Vander Borght et al., 1995) 
